# 21 C.F.R. § 201.6 (2026): Drugs; misleading statements

> Federal · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_6

## Section

- **Citation:** 21 C.F.R. § 201.6 (2026)
- **Heading:** Drugs; misleading statements
- **Jurisdiction:** Federal
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** Title 21 CFR: Food and Drugs / Chapter I / Part 201 / Subpart A / § 201.6: § 201.6   Drugs › misleading statements.

## Text

(a) Among representations in the labeling of a drug which render such drug misbranded is a false or misleading representation with respect to another drug or a device or a food or cosmetic. (b) The labeling of a drug which contains two or more ingredients may be misleading by reason, among other reasons, of the designation of such drug in such labeling by a name which includes or suggests the name of one or more but not all such ingredients, even though the names of all such ingredients are stated elsewhere in the labeling. [41 FR 6908, Feb. 13, 1976]

## Nearby sections

- [21 C.F.R. § 201.1 (2026) § 201.1   Drugs; name and place of business of manufacturer, packer, or distributor.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_1.md)
- [21 C.F.R. § 201.2 (2026) § 201.2   Drugs and devices; National Drug Code numbers.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_2.md)
- [21 C.F.R. § 201.5 (2026) § 201.5   Drugs; adequate directions for use.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_5.md)
- [21 C.F.R. § 201.6 (2026) § 201.6   Drugs; misleading statements.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_6.md)
- [21 C.F.R. § 201.10 (2026) § 201.10   Drugs; statement of ingredients.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_10.md)
- [21 C.F.R. § 201.15 (2026) § 201.15   Drugs; prominence of required label statements.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_15.md)
- [21 C.F.R. § 201.16 (2026) § 201.16   Drugs; Spanish-language version of certain required statements.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_16.md)
- [21 C.F.R. § 201.17 (2026) § 201.17   Drugs; location of expiration date.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_17.md)
- [21 C.F.R. § 201.18 (2026) § 201.18   Drugs; significance of control numbers.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_18.md)
- [21 C.F.R. § 201.19 (2026) § 201.19   Drugs; use of term “infant”.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_19.md)
- [21 C.F.R. § 201.20 (2026) § 201.20   Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_20.md)
- [21 C.F.R. § 201.21 (2026) § 201.21   Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_21.md)
- [21 C.F.R. § 201.22 (2026) § 201.22   Prescription drugs containing sulfites; required warning statements.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_22.md)
- [21 C.F.R. § 201.23 (2026) § 201.23   Required pediatric studies.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_23.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/CFR_T21_P201_S201_6. Check the current official text before relying on it. Not legal advice.